{"contacts": [{"terms": [{"accession": "MS:1000586", "name": "contact name", "value": "Jeremy Balsbaugh"}, {"accession": "MS:1000589", "name": "contact email", "value": "jeremy.balsbaugh@uconn.edu"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "University of Connecticut"}, {"accession": "MS:1002037", "name": "dataset submitter"}]}, {"terms": [{"accession": "MS:1002332", "name": "lab head"}, {"accession": "MS:1000586", "name": "contact name", "value": "Jeremy Balsbaugh"}, {"accession": "MS:1000589", "name": "contact email", "value": "jeremy.balsbaugh@uconn.edu"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "Director, UConn Proteomics & Metabolomics Facility, University of Connecticut, CT, USA"}]}], "datasetFiles": [{"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/04/PXD016814/jlb20190124_AMara_membraneprep.raw"}, {"accession": "MS:1002845", "name": "Associated file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/04/PXD016814/CP010538_faa.fasta"}, {"accession": "MS:1002849", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/04/PXD016814/combined.zip"}], "description": "Vaccine-enhanced disease (VED) occurs as a result of vaccination followed by infection with virulent Mycoplasma pneumoniae. To date, VED has prevented development of an efficacious vaccine against this significant human respiratory pathogen. Herein we report that vaccination with M. pneumoniae lipid-associated membrane proteins (LAMPs) induces lung lesions consistent with exacerbated disease following challenge, without reducing bacterial loads. Removal of lipid moieties from LAMPs prior to vaccination eliminates VED and reduces bacterial loads after infection. Collectively, these data indicate that lipid moieties of lipoproteins are the causative factors of M. pneumoniae VED.", "fullDatasetLinks": [{"accession": "MS:1002852", "name": "Dataset FTP location", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/04/PXD016814"}, {"accession": "MS:1001930", "name": "PRIDE project URI", "value": "http://www.ebi.ac.uk/pride/archive/projects/PXD016814"}], "identifiers": [{"accession": "MS:1001919", "name": "ProteomeXchange accession number", "value": "PXD016814"}, {"accession": "MS:1001921", "name": "ProteomeXchange accession number version number", "value": "2"}], "instruments": [{"accession": "MS:1001911", "name": "Q Exactive"}], "keywords": [{"accession": "MS:1001925", "name": "submitter keyword", "value": "mycoplasma pneumoniae, lipid associated membrane proteins, Q Exactive HF"}], "modifications": [{"accession": "MOD:00425", "name": "monohydroxylated residue"}, {"accession": "MOD:00394", "name": "acetylated residue"}, {"accession": "MOD:00397", "name": "iodoacetamide derivatized residue"}], "publications": [{"terms": [{"accession": "MS:1000879", "name": "PubMed identifier", "value": "32284882"}, {"accession": "MS:1002866", "name": "Reference", "value": "Mara AB, Gavitt TD, Tulman ER, Geary SJ, Szczepanek SM. Lipid moieties of Mycoplasma pneumoniae lipoproteins are the causative factor of vaccine-enhanced disease. NPJ Vaccines. 2020 5:31"}]}], "species": [{"terms": [{"accession": "MS:1001469", "name": "taxonomy: scientific name", "value": "Mycoplasma pneumoniae 19294"}, {"accession": "MS:1001467", "name": "taxonomy: NCBI TaxID", "value": "1213463"}]}], "title": "Lipid moieties of Mycoplasma pneumoniae lipoproteins are the causative factors of vaccine-enhanced disease"}